Clinic
Ali Nasser MD PC
Ali Nasser MD PC was paid $4.18M by Medicaid between Jan 2018 and Dec 2024, across 72 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 51% of everything it billed.
33Billing provider infoALI NASSER MD PC
DEARBORN, MI 48120
DEARBORN, MI 48120
33aNPI1386839215assigned 09/13/2007
33bProvider typePrimary Care Clinic/Center
28Total paid$4.18M
24GClaims219,100
24DCodes billed72
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Michigan
Rank by total paid#7 of 113
Median peer was paid$164K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,334 | $462K | |
| 2019 | 26,102 | $501K | |
| 2020 | 23,899 | $490K | |
| 2021 | 33,377 | $643K | |
| 2022 | 39,371 | $711K | |
| 2023 | 42,551 | $784K | |
| 2024incomplete | 32,466 | $589K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 51% | 33,658 | 28,625 | $2.13M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 6,480 | 6,157 | $560K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 10% | 4,764 | 4,740 | $419K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 7.8% | 3,347 | 3,324 | $324K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.1% | 1,555 | 1,548 | $131K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.6% | 1,272 | 1,268 | $109K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.5% | 2,566 | 2,374 | $104K |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 15,774 | 14,968 | $50K |
| 92552 | 1.1% | 2,405 | 2,385 | $47K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.1% | 617 | 609 | $46K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.1% | 4,329 | 4,251 | $45K |
| 90756 | <1% | 1,812 | 1,777 | $39K |
60 more codes
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,287 | $28K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,435 | $19K |
| 81003 | <1% | 10,214 | $19K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,226 | $16K |
| 96127 | <1% | 4,676 | $13K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 296 | $12K |
| 36416 | <1% | 3,490 | $10K | |
| 99051 | <1% | 6,176 | $9K | |
| 85018 | <1% | 2,966 | $6K | |
| 82962 | <1% | 2,589 | $6K | |
| 90661 | <1% | 194 | $4K | |
| 81025 | <1% | 577 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 559 | $4K |
| 93000 | <1% | 443 | $4K | |
| 99401 | <1% | 1,101 | $3K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 38 | $3K |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 82 | $2K |
| 99385 | <1% | 12 | $1K | |
| 0011A | <1% | 43 | $1K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 858 | $1K |
| 82044 | <1% | 267 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 540 | $1K |
| 83014 | <1% | 407 | $1K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 13 | $901.85 |
| 99000 | <1% | 72 | $628.96 | |
| 99497 | <1% | 117 | $561.68 | |
| 0012A | <1% | 12 | $473.14 | |
| 96160 | <1% | 139 | $288.85 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 74 | $280.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 18 | $221.67 |
| 97802 | <1% | 1,403 | $61.14 | |
| 90686 | <1% | 273 | $57.09 | |
| G0008 | Administration of influenza virus vaccine | <1% | 78 | $17.74 |
| 3079F | <1% | 10,814 | $0.86 | |
| 3078F | <1% | 18,066 | $0.84 | |
| 3075F | <1% | 7,862 | $0.73 | |
| 3077F | <1% | 4,900 | $0.72 | |
| 3074F | <1% | 19,156 | $0.71 | |
| 3080F | <1% | 2,988 | $0.46 | |
| 3008F | <1% | 29,645 | $0.07 | |
| 90649 | <1% | 148 | $0.04 | |
| 90674 | <1% | 89 | $0.03 | |
| 3051F | <1% | 13 | $0.01 | |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 235 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 1,284 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 820 | $0.00 |
| 90670 | 0% | 28 | $0.00 | |
| 90633 | 0% | 49 | $0.00 | |
| 90734 | 0% | 55 | $0.00 | |
| 90715 | 0% | 60 | $0.00 | |
| 90713 | 0% | 27 | $0.00 | |
| 90707 | 0% | 25 | $0.00 | |
| 90648 | 0% | 13 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 1,181 | $0.00 |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 41 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 65 | $0.00 |
| 3044F | 0% | 73 | $0.00 | |
| 91301 | 0% | 91 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 68 | $0.00 |
| 90716 | 0% | 50 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNASSSER, ALI (PRESIDENT)
Parent organizationALI NASSER MD PC